Indication
Ras Gene Mutation
4 clinical trials
5 products
Clinical trial
A First-in-Human (FiH) Study of IK-595, an Oral Dual MEK/RAF Inhibitor, in Patients With RAS-or RAF-altered Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2027-07-01
Product
IK-595Clinical trial
A Phase I, Open Label Single-arm Two-part Study to Investigate Safety, Pharmacokinetics, and Preliminary Efficacy of Pan-RAF/MEK Glue NST-628 Oral Tablets in Subject With Solid Tumors Harboring Genetic Alterations in the MAPK Pathway and With Other Solid TumorsStatus: Recruiting, Estimated PCD: 2028-11-01
Product
NST-628Clinical trial
New Therapeutic Approaches for Tumors With RAS Gene MutationsStatus: Recruiting, Estimated PCD: 2026-10-01
Product
LeflunomideClinical trial
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)Status: Recruiting, Estimated PCD: 2025-12-01